SHAZIA BILLAL: Open Payments
NPI 1144270448 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 49 payments from 18 companies in 2025. Trend: 2023 $1,632 · 2024 $1,860 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $168 |
| AstraZeneca Pharmaceuticals LP | 7 | $153 |
| Hologic Sales and Service, LLC | 1 | $121 |
| Lilly USA, LLC | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Amgen Inc. | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Exact Sciences Corporation | 2 | $47 |
| PFIZER INC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $43 |
Products named: TRELEGY ELLIPTA, THINPREP 2000 PROCESSOR, AIRSUPRA, MOUNJARO, REXULTI, XIFAXAN, JARDIANCE, VRAYLAR.
Industry payments across TX — which companies pay providers there.
